Rating History for Pacira Pharmaceuticals (PCRX) by Brean Capital

More Stocks Rated by Brean Capital | Latest Ratings for PCRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/7/2016 N/A New Coverage Neutral
(N/A)		 N/A
(N/A)		 34.76
(24.36)		 -29.92% Details